Effectiveness of generic tofacitinib in idiopathic inflammatory myositis (IIM)-a retrospective analysis from Indian Myositis Registry (MyoIN).
Vineeta ShobhaRamyaSri KodaliSanjiv N AminPuja SrivastavaBanwari SharmaRuchika GoelArvind GanapatiSachin DhoteRamya JanardanaLiza RajasekharRamnath MisraPublished in: Clinical rheumatology (2024)
• This multicenter retrospective study is the first real-world data from India, elucidating steroid sparing efficacy of generic tofacitinib in patients with inflammatory myositis. • Domain-based outcome assessment suggests good clinical improvement especially in cutaneous domain, even those with refractory disease. • Modest benefits were evident in calcinosis, but its effect on the muscle and pulmonary domain appears limited.
Keyphrases
- interstitial lung disease
- rheumatoid arthritis
- myasthenia gravis
- oxidative stress
- randomized controlled trial
- systematic review
- systemic sclerosis
- pulmonary hypertension
- ulcerative colitis
- skeletal muscle
- electronic health record
- clinical trial
- cross sectional
- robot assisted
- idiopathic pulmonary fibrosis
- big data
- minimally invasive
- artificial intelligence